GlassScriptPhysician profile
Franco E Vigna
NPI 1760489736
$261,280.40
in general payments reported to CMS, 2019-2025
29 companies · $14K in 2025
The $14K reported for 2025 was more than what 75% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $57K · 2021: $48K · 2022: $51K · 2023: $2,854 · 2024: $16K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $32K · Food and Beverage: $1,349 · Education: $65.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $31,980.56 |
| Food and Beverage | $1,349.14 |
| Education | $65.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $221,393.74 | 2019-2022 | |
| Xtant Medical INC | $32,313.39 | 2023-2025 | |
| Abbott Laboratories | $5,230.58 | 2019-2023 | Penta |
| Boston Scientific Corporation | $525.92 | 2019-2022 | |
| Medtronic, INC. | $262.96 | 2021-2024 | Intellis Adaptivestim |
| Novapproach Spine, LLC | $250.00 | 2025 | Onelif |
| Nevro Corp. | $216.08 | 2020-2024 | Senza |
| Si-Bone, INC. | $213.17 | 2019-2025 | |
| Cerapedics INC. | $87.15 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Avanos Medical | $84.40 | 2025 | Generator |
| Depuy Synthes Sales INC. | $71.98 | 2023-2024 | Conduit, Vivigen Mis Delivery System, Viper |
| Zimmer Biomet Holdings, INC. | $70.94 | 2019 | |
| Merck Sharp & Dohme LLC | $62.15 | 2019-2024 | Bridion |
| Djo, LLC | $54.91 | 2025 | Cmf |
| Bioventus LLC | $51.77 | 2023-2025 | Bonescalpel & Sonicone (O.R.), Bonescalpel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $45.83 | 2019 | |
| Smith+Nephew, INC. | $38.09 | 2020 | |
| Baxter Healthcare | $32.34 | 2024 | Floseal |
| Ossur Americas, INC. | $32.22 | 2025 | Unloader One X |
| Solventum Corporation | $31.83 | 2025 | Activ.A.C., Snap |
| Stryker Corporation | $30.02 | 2022 | |
| Organogenesis INC. | $26.73 | 2025 | Puraply Wound Matrix |
| Averitas Pharma INC. | $26.58 | 2025 | Qutenza |
| Curonix LLC | $25.47 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $23.90 | 2025 | Exparel |
| Coastal Medical Technologies LLC | $22.06 | 2025 | |
| Amgen INC. | $20.67 | 2025 | Evenity |
| Kci USA, INC. | $20.18 | 2023 | Prevena |
| Aesculap, INC. | $15.34 | 2024 | Aesculap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franco Vigna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.